PDA for Kidneys Study

Recruiting Observational Study
Patent Ductus Arteriosus Congenital Heart Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Minute – 7 Days
Sex
Any
Study type
Observational
Participants needed
45 (estimated)
Sponsor
University of Wisconsin, Madison · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Delivered at \<32 weeks' gestation * ≤72 hours of age * Inpatient at Meriter Hospital, Inc. NICU * At least one parent/guardian is able to provide parental permission in English or Spanish Exclusion Criteria: * Major congenital anomalies of kidney * Attending physician's dis…
Contacts

Paige Condit, MD

616-481-9914

pcondit@wisc.edu

CONTACT

Meg Baker

meg.baker@wisc.edu

CONTACT